Jakap Koo insider trades

Open-market stock purchases and sales by Jakap Koo, Director at Apimeds Pharmaceuticals US, Inc, from SEC Form 4 filings since May 12, 2025.

Recent trades

DateStockTradeValue
Nov 11, 2025APUS Apimeds Pharmaceuticals US, IncBought (not open market)—
Oct 15, 2025APUS Apimeds Pharmaceuticals US, IncBought (not open market)—

Companies traded

  • APUS Apimeds Pharmaceuticals US, Inc: 1 buy, last Nov 11, 2025

Get free alerts when Jakap Koo files a new trade →